Skip to main content
Log in

85/m mit Blasen am gesamten Integument

Vorbereitung auf die Facharztprüfung: Folge 25

85-year-old male with cutaneous blisters

Preparation for the medical specialist examination: Part 25

  • Mein Facharzttraining
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320–332. https://doi.org/10.1016/S0140-6736(12)61140-4

    Article  PubMed  Google Scholar 

  2. Hübner F, Recke A, Zillikens D et al (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol 136:2495–2498. https://doi.org/10.1016/j.jid.2016.07.013

    Article  CAS  PubMed  Google Scholar 

  3. Goletz S, Zillikens D, Schmidt E (2017) Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 26:1154–1162. https://doi.org/10.1111/exd.13446

    Article  CAS  PubMed  Google Scholar 

  4. Ludwig RJ, Vanhoorelbeke K, Leypoldt F et al (2017) Mechanisms of autoantibody-induced pathology. Front Immunol 8. https://doi.org/10.3389/fimmu.2017.00603

    Article  PubMed  PubMed Central  Google Scholar 

  5. Varpuluoma O, Försti A‑K, Jokelainen J et al (2018) Vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish nationwide registry study. J Invest Dermatol 138:1659–1661. https://doi.org/10.1016/j.jid.2018.01.027

    Article  CAS  PubMed  Google Scholar 

  6. Siegel J, Totonchy M, Damsky W et al (2018) Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: a retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2018.07.008

    Article  PubMed  Google Scholar 

  7. Kridin K, Ludwig RJ (2018) The growing incidence of bullous pemphigoid: overview and potential explanations. Front Med 5. https://doi.org/10.3389/fmed.2018.00220

    Article  Google Scholar 

  8. Försti A‑K, Huilaja L, Schmidt E, Tasanen K (2017) Neurological and psychiatric associations in bullous pemphigoid-more than skin deep? Exp Dermatol 26:1228–1234. https://doi.org/10.1111/exd.13401

    Article  CAS  PubMed  Google Scholar 

  9. Bech R, Kibsgaard L, Vestergaard C (2018) Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing literature. Front Med 5. https://doi.org/10.3389/fmed.2018.00238

    Article  Google Scholar 

  10. Holtsche MM, Zillikens D, Schmidt E (2018) Mucous membrane pemphigoid. Hautarzt 69:67–83. https://doi.org/10.1007/s00105-017-4089-y

    Article  CAS  PubMed  Google Scholar 

  11. Schmidt E, della Torre R, Borradori L (2012) Clinical features and practical diagnosis of bullous pemphigoid. Immunol Allergy Clin North Am 32:217–232. https://doi.org/10.1016/j.iac.2012.04.002

    Article  PubMed  Google Scholar 

  12. Schulze F, Kasperkiewicz M, Zillikens D, Schmidt E (2013) Bullous pemphigoid. Hautarzt 64:931–943. https://doi.org/10.1007/s00105-013-2599-9 (quiz 944–945)

    Article  CAS  PubMed  Google Scholar 

  13. Schmidt E, Zillikens D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399–405. https://doi.org/10.3238/arztebl.2011.0405

    Article  PubMed  PubMed Central  Google Scholar 

  14. van Beek N, Zillikens D, Schmidt E (2018) Diagnostik blasenbildender Autoimmundermatosen. J Dtsch Dermatol Ges 16:1077–1092. https://doi.org/10.1111/ddg.13637_g

    Article  PubMed  Google Scholar 

  15. Schmidt E, Goebeler M, Hertl M et al (2015) S2k-Leitlinie zur Diagnostik des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: Diagnostik Pemphigus und bullöses Pemphigoid. J Dtsch Dermatol Ges 13:713–727. https://doi.org/10.1111/ddg.40_12612

    Article  PubMed  Google Scholar 

  16. Vodegel RM, Jonkman M, Pas HH, De Jong MCJM (2004) U‑serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 151:112–118. https://doi.org/10.1111/j.1365-2133.2004.06006.x

    Article  CAS  PubMed  Google Scholar 

  17. Meijer JM, Atefi I, Diercks GFH et al (2018) Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. J Am Acad Dermatol 78(4):754–759.e6. https://doi.org/10.1016/j.jaad.2017.11.029

    Article  PubMed  Google Scholar 

  18. van Beek N, Rentzsch K, Probst C et al (2012) Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49. https://doi.org/10.1186/1750-1172-7-49

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sticherling M, Franke A, Aberer E et al (2017) An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. Br J Dermatol 177:1299–1305. https://doi.org/10.1111/bjd.15649

    Article  CAS  PubMed  Google Scholar 

  20. Williams HC, Wojnarowska F, Kirtschig G et al (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet 389:1630–1638. https://doi.org/10.1016/S0140-6736(17)30560-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hübner F, Kasperkiewicz M, Knuth-Rehr D et al (2018) Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption. J Dtsch Dermatol Ges 16:1109–1118. https://doi.org/10.1111/ddg.13642

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mareike Witte.

Ethics declarations

Interessenkonflikt

M. Witte, E. Schmidt und R. Ludwig geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

The supplement containing this article is not sponsored by industry.

Additional information

Redaktion

E. von Stebut, Köln

Redaktionelle Mitarbeit

R. Eming, Marburg

P. Moinzadeh, Köln

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Witte, M., Schmidt, E. & Ludwig, R. 85/m mit Blasen am gesamten Integument. Hautarzt 69 (Suppl 2), 183–188 (2018). https://doi.org/10.1007/s00105-018-4291-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-018-4291-6

Schlüsselwörter

Navigation